Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

about

Saving costs in cancer patient management through molecular imaging.Tracking of transplanted human umbilical cord-derived mesenchymal stem cells labeled with fluorescent probe in a mouse model of acute lung injury.

P2860

Q47123424-008BF3B3-576B-4CE6-9C37-7B0A68B09138 Q52658579-2782408A-1FA8-4477-AE07-91EBCC5CD6BB

P2860

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q38716531

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

@en

type

Item

label

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

@en

prefLabel

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

@en

P1476

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

@en

P2093

Agustina Banchero

http://www.w3.org/2001/XMLSchema#string

Camila Longo Machado

http://www.w3.org/2001/XMLSchema#string

Carolina Rosal

http://www.w3.org/2001/XMLSchema#string

Daniela Bertolini Zanatta

http://www.w3.org/2001/XMLSchema#string

Juan Pablo Gambini

http://www.w3.org/2001/XMLSchema#string

Marcelo Fernández

http://www.w3.org/2001/XMLSchema#string

Natalia Oddone

http://www.w3.org/2001/XMLSchema#string

Pablo Cabral

http://www.w3.org/2001/XMLSchema#string

Roger Chammas

http://www.w3.org/2001/XMLSchema#string

Ximena Camacho

http://www.w3.org/2001/XMLSchema#string

P2860

Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents

The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy.

Anti-CD20-based therapy of B cell lymphoma: state of the art.

Radioimmunotherapy of non-Hodgkin lymphomas.

(99m)Tc-labeled rituximab for imaging B lymphocyte infiltration in inflammatory autoimmune disease patients.

The therapeutic potential of anti-CD20 "what do B-cells do?".

Radioimmunotherapy as a therapeutic option for Non-Hodgkin's lymphoma.

Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins.

P304

229-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000452419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Alberto Buchpiguel

Eloisa Riva

María Fernanda García

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28196364

http://www.w3.org/2001/XMLSchema#string

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

about

P2860

P2860

Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698